Are you Dr. Roy?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4975 Bradenton Ave
Dublin, OH 43017Phone+1 614-766-0773Fax+1 614-766-2599
Summary
- Dr. Asim Roy, MD is a board certified neurologist in Dublin, Ohio. He is currently licensed to practice medicine in Ohio, Pennsylvania, and Massachusetts. He is affiliated with OhioHealth Riverside Methodist Hospital.
Education & Training
Cleveland Clinic FoundationFellowship, Clinical Neurophysiology, 2005 - 2006
OhioHealth/Riverside Methodist HospitalInternship, Internal Medicine, 2001 - 2002
Northeast Ohio Medical UniversityClass of 2001
Certifications & Licensure
OH State Medical License 2001 - 2026
PA State Medical License 2008 - 2012
MA State Medical License 2006 - 2009
DC State Medical License 2003 - 2006- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Sleep Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2013
Clinical Trials
- Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea Start of enrollment: 2019 Sep 23
Publications & Presentations
PubMed
- 24 citationsOnce-Nightly Sodium Oxybate (FT218) Demonstrated Improvement of Symptoms in a Phase 3 Randomized Clinical Trial in Patients With Narcolepsy.Clete A. Kushida, Colin M. Shapiro, Thomas Roth, Michael J. Thorpy, Bruce C. Corser
Sleep. 2021-08-06 - Dosing Optimization of Low-Sodium Oxybate in Narcolepsy and Idiopathic Hypersomnia in Adults: Consensus Recommendations.Anne Marie Morse, Richard K Bogan, Asim Roy, Michael J Thorpy
Neurology and Therapy. 2024-06-01 - 4 citationsAdjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial.Mark J Buchfuhrer, Asim Roy, Stephanye Rodriguez, Jonathan D Charlesworth
BMC Neurology. 2023-11-21
Press Mentions
Narcolepsy Medication Lumryz Linked to Weight LossAugust 20th, 2024- ZOLL Remedē System, a Breakthrough Therapy for Treating Central Sleep Apnea, Receives Approval for MRI Conditional UseMay 25th, 2023
- ZOLL Remedē System Receives FDA Approval for Sleep Apnoea TreatmentMay 25th, 2023
- Join now to see all
